|
||||||||
![]() |
||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]()
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced. |
|||||||||||||||||||||||||||||||||||||||||||||||||
![]() Download
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Nhe I | Bgl II | Sac I | Hind III | EcoR I | Sal I | Kpn I | Apa I | BamH I | Age I | TurboRFP | |||||||||||||||||
| Afe I | Xho I | Pst I | Sac II | ||||||||||||||||||||||||
| GCT | A.GC | G.CT | A.CCG.GAC.TC | A.GAT. | CT | C. | GAG. | CTC. | AAG.CTT. | C | GA.ATT. | C | TG.CA | G. | TCG.AC | G.GTA. | CC | G.C | GG. | G | CC.C | G | G.G | AT.CC | A.CCG.GT | C.GCC.ACC. | ATG.AGC.GAG |
pTurboRFP-N is a mammalian expression vector encoding red (orange) fluorescent protein TurboRFP (see protein description). The vector allows generation of fusions to the TurboRFP N-terminus and expression of TurboRFP fusions or TurboRFP alone in eukaryotic (mammalian) cells.
TurboRFP codon usage is optimized for high expression in mammalian cells (humanized) [Haas et al., 1996]. To increase mRNA translation efficiency, Kozak consensus translation initiation site is generated upstream of TurboRFP sequence [Kozak, 1987]. Multiple cloning site (MCS) is located between PCMV IE and TurboRFP coding sequence.
The vector backbone contains immediate early promoter of cytomegalovirus (PCMV IE) for reporter expression, SV40 origin for replication in mammalian cells expressing SV40 T-antigen, pUC origin of replication for propagation in E. coli and f1 origin for single-stranded DNA production. SV40 polyadenylation signals (SV40 poly A) direct proper processing of the 3'-end of the reporter mRNA.
SV40 early promoter (PSV40) provides neomycin resistance gene (Neor) expression to select stably transfected eukaryotic cells using G418. Bacterial promoter (P) provides kanamycin resistance gene expression (Kanr) in E. coli. Kanr/Neor gene is linked with herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signals.
Generation of TurboRFP-tagged fusions
A localization signal or a gene of interest should be cloned into MCS of the vector. It will be expressed as a fusion to the TurboRFP N-terminus when inserted in the same reading frame as TurboRFP and no in-frame stop codons are present. The inserted sequence should contain an initiating ATG codon. TurboRFP-tagged fusions retain fluorescent properties of the native protein allowing fusion localization in vivo. Unmodified vector will express TurboRFP, when transfected into eukaryotic (mammalian) cells.
Note: The plasmid DNA was isolated from dam+-methylated E.coli. Therefore some restriction sites are blocked by methylation. If you wish to digest the vector using such sites you will need to transform the vector into a dam- host and make fresh DNA.
Expression in mammalian cells
The vector can be transfected into mammalian cells by any known transfection method. CMV promoter provides strong, constitutive expression of TurboRFP or its fusions in many cell types. If required, stable transformants can be selected using G418 [Gorman, 1985].
Propagation in E. coli
Suitable host strains for propagation in E. coli include DH5alpha, HB101, XL1-Blue, and other general purpose strains. Plasmid incompatibility group is pMB1/ColE1. The vector confers resistance to kanamycin (30 μg/ml) to E. coli hosts. Copy number in E. coli is about 500.
Location of features
PCMV IE: 1-589
Enhancer region: 59-465
TATA box: 554-560
Transcription start point: 583
MCS: 591-671
Turbo-RFP
Kozak consensus translation initiation site: 672-682
Start codon (ATG): 679-681
Stop codon: 1375-1377
SV40 early mRNA polyadenylation signal
Polyadenylation signals: 1528-1533 & 1557-1562
mRNA 3' ends: 1566 & 1578
f1 single-strand DNA origin: 1625-2080
Eukaryotic promoter for expression of Kanr gene
-35 region: 2142-2147
-10 region: 2165-2170
Transcription start point: 2177
SV40 origin of replication: 2421-2556
SV40 early promoter
Enhancer (72-bp tandem repeats): 2254-2325 & 2326-2397
21-bp repeats: 2401-2421, 2422-2442 & 2444-2464
Early promoter element: 2477-2483
Major transcription start points: 2473, 2511, 2517 & 2522
Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 2605-2607
Stop codon: 3397-3399
G->A mutation to remove Pst I site: 2787
C->A (Arg to Ser) mutation to remove BssH II site: 3133
Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 3635-3640 & 3648-3653
pUC plasmid replication origin: 3984-4627
Evrogen FP-related products are intended for research use only and covered by Evrogen Patents and/or Patent applications pending. By use of these products, you accept the terms and conditions of the applicable Limited Use Label License.
The CMV promoter is covered under U.S. Patents 5,168,062 and 5,385,839, and its use is permitted for research purposes only. Any other use of the CMV promoter requires a license from the University of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242.
To the best of our knowledge, these products do not require a Material Safety Data Sheet. However, all the properties of these products (and, if applicable, each of their components) have not been thoroughly investigated. Therefore, we recommend that you use gloves and eye protection, and wear a laboratory coat when working with these products.
|
Copyright 2002-2008 Evrogen. All rights reserved. Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, +7(495)4298020, e-mail:evrogen@evrogen.com |